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 Characterization of Antibiotic Use for Acute Otitis Media 
in Pediatric Physician Practices 
Jasica Truong, PharmD; Kristin Held Wheatley, PharmD, BCOP; Jennifer Macfarlan, MPH; Tibisay Villalobos-Fry, MD, FAAP
Lehigh Valley Health Network, Allentown, Pennsylvania
PURPOSE
•  The objective of this retrospective chart review is to report 
compliance in antibiotic prescribing for acute otitis media (AOM) 
based on current guidelines among the Lehigh Valley Physician 
Group (LVPG) pediatric practices. 
BACKGROUND
•  AOM is one of the most common infections affecting more than 
50% of children by the age of 5 years
•  Wide availability of antibiotic therapies to manage AOM may lead to 
unnecessarily broad therapy
•  Compliance with current guidelines is necessary to limit antibiotic use 
 -  American Academy of Pediatrics (AAP) Clinical Practice Guidelines 
recommend high-dose amoxicillin as first-line treatment for AOM 
and additional beta-lactamase coverage if certain conditions are met 
 -  Alternative antibiotics for AOM include second- or third-generation 
cephalosporins
 -  Patients with otitis media with effusion (OME) should not receive 
antibiotics 
•  Review of prescribing practices for AOM expands network’s 
outpatient antimicrobial stewardship efforts
 -  Pediatric practices will be provided feedback regarding 
compliance with current guidelines
STUDY DESIGN
•  Retrospective chart review of electronic medical records in LVPG 
pediatric physician practices
•  Inclusion criteria 
 -  Age 6 months to 12 years observed or prescribed antibiotic treatment
 -  Diagnosis of AOM or OME
•  Exclusion criteria
 -  Patients with underlying conditions that may alter the natural 
course of AOM including immunodeficiency or immunosuppressive 
therapy; tympanostomy tubes at the time of diagnosis; craniofacial 
abnormalities; cystic fibrosis; concomitant bacterial infections 
involving other sites or systemic bacterial infection; chronic otitis 
media; and AOM complicated by mastoiditis
•  Primary objective
 -  Report compliance with first and second line antibiotic regimens 
based on current AOM guidelines among pediatric physician practices
•  Secondary objectives
 -  Characterize first and second line antibiotic regimens for 
management of AOM
 -  Evaluate the percentage of ceftriaxone prescribed in therapy as 
first line, second line, and third line in outpatient physician 
practices
 -  Report compliance with observation only for OME
 -  Evaluate differences in antibiotic prescribing between pediatric 
physician practices for AOM and OME
METHODS
•  Office visits to LVPG pediatric practices between June 1, 2016 and 
May 31, 2018 will be reviewed
•  Data to be collected includes:
 -  Age, gender, weight, past episodes of AOM, antibiotic history in 
past 30 days, drug allergy history, exposure to day care 
 -  Office visit dates and location, provider name, diagnosis, availability 
of respiratory pathogen profile within one week of office visit
 -  Antibiotic regimen prescribed: dose, route, frequency, duration
•  Compliance will be reported as frequency of diagnoses treated 
according to AOM guidelines
 -  Percentage of antibiotics prescribed as first and second line will 
be reported
 -  Prescribed antibiotics will be further stratified by: 
    Location of practice
    Seasonality of visit date (Summer, Fall, Winter, Spring)
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